Grocery Dive reports the supermarket chain is adding guided store tours built for shoppers taking GLP-1 medications.
Recap by typeshit. Full story at Grocery Dive.
Chokshi notes the sales were 0.4% of Lilly's $23 billion quarter, and that Divi's Labs hasn't announced any role in making the drug.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
She says the cause is a calorie surplus: some patients still manage high calorie foods and aren't exercising enough while on the drugs.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
A study of 300 million Epic records at the AAO meeting found an early risk signal flipped once diabetes, blood pressure and cholesterol were accounted for.
The American Academy of Ophthalmology reports that among patients with optic nerve strokes in both eyes, the second eye was hit faster on GLP-1s.
Loading…